Module 1 2021

Approval/Review Pathways

• Type of approval

− ‘Regular’ Approval − Accelerated Approval

37

37

‘Regular’ Approval

• On completion of Phase 3 clinical studies • Full data package − Application with sufficient data to demonstrate » Safety and Efficacy » Clinical Benefit

38

38

19